This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1994-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tsukuba, JP (1994)
- Hyogo, JP (2003)
Company Filing History:
Years Active: 1994-2003
Title: Kunio Nakahara: Innovator in Dermatological Therapies
Introduction
Kunio Nakahara is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of dermatology, particularly in the development of compositions aimed at preventing and treating skin aging. His innovative work has led to the filing of multiple patents, showcasing his expertise and dedication to advancing medical science.
Latest Patents
Nakahara holds 2 patents that focus on dermatological health. His latest patents include a composition for prophylaxis and therapy of dermal aging, which comprises a substance with human leukocyte elastase inhibitory activity as an active ingredient. Additionally, he has developed a prophylactic and therapeutic composition for disseminated intravascular coagulation, characterized by administering an effective dose of WS7622A mono- or di-sulfate ester or their pharmaceutically acceptable salt to patients in need.
Career Highlights
Throughout his career, Nakahara has worked with prominent companies in the pharmaceutical industry. He has been associated with Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH, where he has contributed to various research and development projects aimed at improving patient outcomes.
Collaborations
Nakahara has collaborated with esteemed colleagues, including Yasuhiko Shinguh and Mitsuru Yasumura. These partnerships have further enhanced his research capabilities and have led to the successful development of innovative therapeutic solutions.
Conclusion
Kunio Nakahara's contributions to dermatological therapies through his patents and collaborations highlight his role as a significant innovator in the field. His work continues to impact the medical community positively, paving the way for advancements in skin health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
